Jiangsu Kanion Pharmaceutical Co Ltd (600557) — Cash Flow-to-Debt Ratio
Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of CN¥201.83 Million could theoretically repay 0% of its total liabilities (CN¥1.83 Billion) in one year. Explore Jiangsu Kanion Pharmaceutical Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Kanion Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2001–2024)
Historical debt coverage capacity for Jiangsu Kanion Pharmaceutical Co Ltd across 24 annual periods. Also explore Jiangsu Kanion Pharmaceutical Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
Year-by-year debt coverage analysis for Jiangsu Kanion Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 600557 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | CN¥702.49 Million | CN¥2.20 Billion | ▼ -43.0% |
| 2023 | 0.56x | CN¥972.32 Million | CN¥1.74 Billion | ▲ +4.7% |
| 2022 | 0.53x | CN¥995.94 Million | CN¥1.86 Billion | ▼ -9.0% |
| 2021 | 0.59x | CN¥908.30 Million | CN¥1.55 Billion | ▲ +50.2% |
| 2020 | 0.39x | CN¥701.10 Million | CN¥1.79 Billion | ▼ -14.5% |
| 2019 | 0.46x | CN¥925.73 Million | CN¥2.02 Billion | ▲ +23.0% |
| 2018 | 0.37x | CN¥636.39 Million | CN¥1.71 Billion | ▲ +74.9% |
| 2017 | 0.21x | CN¥382.93 Million | CN¥1.80 Billion | ▲ +8.4% |
| 2016 | 0.20x | CN¥299.02 Million | CN¥1.52 Billion | ▼ -45.4% |
| 2015 | 0.36x | CN¥514.80 Million | CN¥1.43 Billion | ▲ +84.3% |
| 2014 | 0.19x | CN¥311.54 Million | CN¥1.60 Billion | ▼ -24.8% |
| 2013 | 0.26x | CN¥388.11 Million | CN¥1.50 Billion | ▲ +80.1% |
| 2012 | 0.14x | CN¥212.11 Million | CN¥1.47 Billion | ▲ +76.5% |
| 2011 | 0.08x | CN¥90.19 Million | CN¥1.11 Billion | ▼ -63.6% |
| 2010 | 0.22x | CN¥166.40 Million | CN¥743.19 Million | ▲ +476.0% |
| 2009 | -0.06x | CN¥-21.87 Million | CN¥367.23 Million | ▼ -136.3% |
| 2008 | 0.16x | CN¥58.39 Million | CN¥355.85 Million | ▼ -16.2% |
| 2007 | 0.20x | CN¥92.73 Million | CN¥473.81 Million | ▼ -20.4% |
| 2006 | 0.25x | CN¥108.98 Million | CN¥443.19 Million | ▲ +29.1% |
| 2005 | 0.19x | CN¥101.44 Million | CN¥532.62 Million | ▲ +225.8% |
| 2004 | 0.06x | CN¥21.68 Million | CN¥370.88 Million | ▲ +37.8% |
| 2003 | 0.04x | CN¥17.13 Million | CN¥403.56 Million | ▼ -64.7% |
| 2002 | 0.12x | CN¥11.15 Million | CN¥92.69 Million | ▼ -40.7% |
| 2001 | 0.20x | CN¥21.02 Million | CN¥103.61 Million | — |